Compounds > edotreotide
Page last updated: 2024-09-04

edotreotide and Cushing Syndrome

edotreotide has been researched along with Cushing Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bélissant Benesty, O; Bertherat, J; Chanson, P; Michaud, L; Montravers, F; Nataf, V; Ohnona, J; Reznik, Y; Talbot, JN; Zhang-Yin, J1
Davi', MV; Francia, G; Salgarello, M1
Dutta, R; Jindal, T; Kumar, A; Kumar, R1

Other Studies

3 other study(ies) available for edotreotide and Cushing Syndrome

ArticleYear
    Endocrine, 2020, Volume: 67, Issue:3

    Topics: Cushing Syndrome; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed

2020
Positive (68)Ga-DOTATOC-PET/CT after cortisol level control during ketoconazole treatment in a patient with liver metastases from a pancreatic neuroendocrine tumor and ectopic Cushing syndrome.
    Endocrine, 2015, Volume: 49, Issue:2

    Topics: Cushing Syndrome; Gallium Radioisotopes; Humans; Hydrocortisone; Ketoconazole; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Octreotide; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed

2015
Role of 68Ga-DOTATOC PET/CT in carcinoids.
    Pathology international, 2010, Volume: 60, Issue:2

    Topics: Carcinoid Tumor; Cushing Syndrome; Humans; Lung Neoplasms; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2010